Roche Tamiflu Ad Letter Continues FDA Scrutiny Of New Flu Drugs
Roche's claim that Tamiflu "reduces the duration of the flu" overstates the efficacy of the drug, FDA maintained in an April 14 letter to Roche.
Roche's claim that Tamiflu "reduces the duration of the flu" overstates the efficacy of the drug, FDA maintained in an April 14 letter to Roche.